Author

Michael Lay

Observed name: Michael D. Lay

Institution: University of Oxford

Observed institutions: University Hospitals Birmingham NHS Foundation Trust, Public Health England, National Institute for Health and Care Research, University of Oxford, Public Health Scotland, National Records of Scotland, Nepal Health Research Council, Oxford University Clinical Research Unit, Intensive Care National Audit & Research Centre, Oxford University Clinical Research Unit Indonesia

OpenAlex ID: A5111839945

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 533

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 493

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324

Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy

2021 · Alison Halliday, Richard Bulbulia, et al. · The Lancet · 318

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 290

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129

Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND)

2016 · ASCEND Study Collaborative Group, Theingi Aung, et al. · Trials · 51

Effects of Vitamin D on Blood Pressure, Arterial Stiffness, and Cardiac Function in Older People After 1 Year: BEST‐D (Biochemical Efficacy and Safety Trial of Vitamin D)

2017 · Joseph Tomson, Harold Hin, et al. · Journal of the American Heart Association · 37

Challenges of linking to routine healthcare records in UK Biobank

2015 · Ligia Adamska, Naomi Allen, et al. · Trials · 19

Estimation of the optimum dose of vitamin D for disease prevention in older people: Rationale, design and baseline characteristics of the BEST-D trial

2015 · Robert Clarke, Connie Newman, et al. · Maturitas · 14

Introduction of electronic data capture method using participant-completed online web-based follow up questionnaire in mail-based study achieves expected benefits and positive participant feedback

2015 · Jill Barton, Allen Young, et al. · Trials · 5

Additional file 2: of Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND)

2016 · Theingi Aung, Richard Haynes, et al. · 2

HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics

2026 · Marion M. Mafham, Mohammed G. Zayed, et al. · American Heart Journal · 1

Quality by design: using intelligent forms to ensure study protocol compliance and participant safety

2015 · Rejive Dayanandan, Elizabeth Wincott, et al. · Trials

Methodology for UK recruitment into a large-scale international clinical trial

2015 · Elizabeth Wincott, Rejive Dayanandan, et al. · Trials

Works count: 16

Citation count: 2,584

H-index: 11

I10-index: 11